Huang Z - Search Results

1

Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.

Song L, Hou Y, Xu D, Dai X, Luo J, Liu Y, Huang Z, Yang M, Chen J, Hu Y, Chen C, Tang Y, Rao Z, Ma J, Zheng M, Shi K, Cai C, Lu M, Tang R, Ma X, Xie C, Luo Y, Li X, Huang Z. Song L, et al. Among authors: huang z. Cell Metab. 2024 Oct 4:S1550-4131(24)00372-3. doi: 10.1016/j.cmet.2024.09.008. Online ahead of print. Cell Metab. 2024. PMID: 39393353

2

FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis.

Song L, Wang L, Hou Y, Zhou J, Chen C, Ye X, Dong W, Gao H, Liu Y, Qiao G, Pan T, Chen Q, Cao Y, Hu F, Rao Z, Chen Y, Han Y, Zheng M, Luo Y, Li X, Chen Y, Huang Z. Song L, et al. Among authors: huang z. Hepatology. 2022 Oct;76(4):1105-1120. doi: 10.1002/hep.32404. Epub 2022 Feb 27. Hepatology. 2022. PMID: 35152446

3

Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.

Zhou C, Pan X, Huang L, Wu T, Zhao T, Qi J, Wu J, Mukondiwa AV, Tang Y, Luo Y, Tu Q, Huang Z, Niu J. Zhou C, et al. Among authors: huang l, huang z. Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166870. doi: 10.1016/j.bbadis.2023.166870. Epub 2023 Sep 9. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 37696161

4

FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis.

Huang Z, Pan T, Xu L, Shi L, Ma X, Zhou L, Wang L, Wang J, Zhu G, Chen D, Song L, Pan X, Wang X, Li X, Luo Y, Chen Y. Huang Z, et al. Acta Pharm Sin B. 2024 Apr;14(4):1605-1623. doi: 10.1016/j.apsb.2023.12.012. Epub 2023 Dec 19. Acta Pharm Sin B. 2024. PMID: 38572102 Free PMC article.

5

Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].

Huang Z, Pan T, Xu L, Shi L, Ma X, Zhou L, Wang L, Wang J, Zhu G, Chen D, Song L, Pan X, Wang X, Li X, Luo Y, Chen Y. Huang Z, et al. Acta Pharm Sin B. 2024 Jun;14(6):2791-2793. doi: 10.1016/j.apsb.2024.04.008. Epub 2024 Apr 9. Acta Pharm Sin B. 2024. PMID: 38828151 Free PMC article.

6

Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4.

Sun H, Lin W, Tang Y, Tu H, Chen T, Zhou J, Wang D, Xu Q, Niu J, Dong W, Liu S, Ni X, Yang W, Zhao Y, Ying L, Zhang J, Li X, Mohammadi M, Shen WL, Huang Z. Sun H, et al. Among authors: huang z. Cell Metab. 2023 Jun 6;35(6):1022-1037.e6. doi: 10.1016/j.cmet.2023.04.018. Epub 2023 May 10. Cell Metab. 2023. PMID: 37167965 Free article.

7

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.

Ying L, Wang L, Guo K, Hou Y, Li N, Wang S, Liu X, Zhao Q, Zhou J, Zhao L, Niu J, Chen C, Song L, Hou S, Kong L, Li X, Ren J, Li P, Mohammadi M, Huang Z. Ying L, et al. Among authors: huang z. Nat Commun. 2021 Dec 14;12(1):7256. doi: 10.1038/s41467-021-27584-y. Nat Commun. 2021. PMID: 34907199 Free PMC article.

8

Paracrine Fibroblast Growth Factor 1 Functions as Potent Therapeutic Agent for Intrahepatic Cholestasis by Downregulating Synthesis of Bile Acid.

Lin H, Zhou C, Hou Y, Li Q, Qiao G, Wang Y, Huang Z, Niu J. Lin H, et al. Among authors: huang z. Front Pharmacol. 2019 Dec 20;10:1515. doi: 10.3389/fphar.2019.01515. eCollection 2019. Front Pharmacol. 2019. PMID: 31920680 Free PMC article.

9

Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability.

Huang Z, Tan Y, Gu J, Liu Y, Song L, Niu J, Zhao L, Srinivasan L, Lin Q, Deng J, Li Y, Conklin DJ, Neubert TA, Cai L, Li X, Mohammadi M. Huang Z, et al. Cell Rep. 2017 Aug 15;20(7):1717-1728. doi: 10.1016/j.celrep.2017.06.063. Cell Rep. 2017. PMID: 28813681 Free PMC article.

10

Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.

Niu J, Xie J, Guo K, Zhang X, Xia F, Zhao X, Song L, Zhuge D, Li X, Zhao Y, Huang Z. Niu J, et al. Among authors: huang z. Drug Deliv. 2018 Nov;25(1):1560-1569. doi: 10.1080/10717544.2018.1482972. Drug Deliv. 2018. PMID: 30043675 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,419 results

Search Page

Filters